Medical Editor: John P. Cunha, DO, FACOEP
Aristocort Forte (triamcinolone diacetate) 40 mg/mL Parenteral is a corticosteroid indicated for intramuscular use to treat allergies, skin diseases, endocrine disorders, gastrointestinal diseases, blood disorders, certain cancers, problems with the nervous system, eye diseases, kidney diseases, respiratory diseases, and rheumatic disorders. The intra-articular or soft tissue administration of Aristocort Forte is indicated as adjunctive therapy for short-term administration in acute gouty arthritis, acute and subacute bursitis, acute nonspecific tenosynovitis, epicondylitis, rheumatoid arthritis, synovitis of osteoarthritis. The intralesional administration of Aristocort Forte is indicated for alopecia areata; discoid lupus erythematosus; keloids; localized hypertrophic, infiltrated, inflammatory lesions of granuloma annulare, lichen planus, lichen simplex chronicus (neurodermatitis), and psoriatic plaques. The brand name Aristocort Forte is discontinued, but generic versions may be available. Common side effects of Aristocort Forte (triamcinolone diacetate) include:
- allergic reactions,
- slow or fast heart rate,
- lightheadedness or fainting,
- dry scaly skin,
- skin redness,
- skin discoloration,
- slow wound healing,
- increased sweating,
- stretch marks,
- thinning skin,
- thinning scalp hair,
- excess hair growth,
- menstrual irregularities,
- fluid retention,
- abdominal bloating,
- increased appetite,
- muscle weakness,
- mood swings,
- numbness and tingling,
- nerve pain,
- spinning sensation (vertigo),
- abnormal fat deposits,
- weight gain,
- puffiness in the face, and
- injection site reactions.
The initial intramuscular dosage of Aristocort Forte (triamcinolone diacetate) injectable suspension may vary from 3 to 48 mg per day depending on the specific disease entity being treated. Aristocort Forte may interact with aminoglutethimide, amphotericin B, diuretics, macrolide antibiotics, anticholinesterases, oral anticoagulants, antidiabetics, isoniazid, cholestyramine, cyclosporine, digitalis glycosides, estrogens (including oral contraceptives), barbiturates, phenytoin, carbamazepine, rifampin, ketoconazole, nonsteroidal anti-inflammatory drugs (NSAIDs), and some vaccines. Tell your doctor all medications and supplements you use and all vaccines you recently received. Tell your doctor if you are pregnant or plan to become pregnant before using Aristocort Forte; it is unknown how it will affect a fetus. Infants born to mothers who have received corticosteroids such as Aristocort Forte during pregnancy should be carefully observed for signs of hypoadrenalism. Systemically administered corticosteroids pass into breast milk and have adverse effects on nursing infants. Breastfeeding while using Aristocort Forte is not recommended.
Our Aristocort Forte (Triamcinolone Diacetate) 40 mg/mL Parenteral Side Effects Drug Center provides a comprehensive view of available drug information on the potential side effects when taking this medication.
This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.
(listed alphabetically, under each subsection)
Bradycardia, cardiac arrest, cardiac arrhythmias, cardiac enlargement, circulatory collapse, congestive heart failure, fat embolism, hypertension, hypertrophic cardiomyopathy in premature infants, myocardial rupture following recent myocardial infarction (see WARNINGS), pulmonary edema, syncope, tachycardia, thromboembolism, thrombophlebitis, vasculitis.
Acne, allergic dermatitis, cutaneous and subcutaneous atrophy, dry scaly skin, ecchymoses and petechiae, edema, erythema, hyperpigmentation, hypopigmentation, impaired wound healing, increased sweating, rash, sterile abscess, striae, suppressed reactions to skin tests, thin fragile skin, thinning scalp hair, urticaria.
Decreased carbohydrate and glucose tolerance, development of cushingoid state, glycosuria, hirsutism, hypertrichosis, increased requirements for insulin or oral hypoglycemic agents in diabetes, manifestations of latent diabetes mellitus, menstrual irregularities, secondary adrenocortical and pituitary unresponsiveness (particularly in times of stress, as in trauma, surgery, or illness), suppression of growth in pediatric patients.
Fluid And Electrolyte Disturbances
Abdominal distention, bowel/bladder dysfunction (after intrathecal administration), elevation in serum liver enzyme levels (usually reversible upon discontinuation), hepatomegaly, increased appetite, nausea, pancreatitis, peptic ulcer with possible perforation and hemorrhage, perforation of the small and large intestine (particularly in patients with inflammatory bowel disease), ulcerative esophagitis.
Aseptic necrosis of femoral and humeral heads, calcinosis (following intra-articular or intra-lesional use), Charcot-like arthropathy, loss of muscle mass, muscle weakness, osteoporosis, pathologic fracture of long bones, postinjection flare (following intra-articular use), steroid myopathy, tendon rupture, vertebral compression fractures.
Convulsions, depression, emotional instability, euphoria, headache, increased intracranial pressure with papilledema (pseudotumor cerebri) usually following discontinuation of treatment, insomnia, mood swings, neuritis, neuropathy, paresthesia, personality changes, psychic disorders, vertigo. Arachnoiditis, meningitis, paraparesis/paraplegia, and sensory disturbances have occurred after intrathecal administration (see WARNINGS: Neurologic).
Abnormal fat deposits, decreased resistance to infection, hiccups, increased or decreased motility and number of spermatozoa, injection site infections following non-sterile administration (see WARNINGS), malaise, moon face, weight gain.
Read the entire FDA prescribing information for Aristocort Forte (Triamcinolone Diacetate)